HMOX1 and glioblastoma: Finally, using a human neocortical GBM model coupled with patient-derived T cells to simulate the lymphoid compartment, we validated the role of HMOX1+ myeloid cells as key drivers for the immunosuppressive microenvironment found in glioblastoma.